Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1

Conditions

Breast Neoplasms 64Neoplasm Metastasis 14Brain Neoplasms 10Neoplasms 9Endometrial Neoplasms 8Prostatic Neoplasms 7Glioblastoma 7Ovarian Neoplasms 6Triple Negative Breast Neoplasms 5Glioma 5Sarcoma 3Recurrence 3Neoplasms by Site 3Meningioma 3Carcinoma, Non-Small-Cell Lung 3Breast Diseases 3Unilateral Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Osteosarcoma 2Liposarcoma 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Ependymoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Advanced Breast Cancer 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

regorafenib 2ivosidenib 2Proton Therapy 2enasidenib 1durvalumab 1capivasertib 1abemaciclib 1Zoledronic Acid 1Weight-Bearing 1Taxes 1Surveys and Questionnaires 1Standard of Care 1Range of Motion, Articular 1Pharmacogenomic Testing 1Paclitaxel 1Immunoglobulin G 1HhAntag691 1Gemcitabine 1Disulfides 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × abemaciclib × 1 year × Clear all
NCT04040205 2025-07-20

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Medical College of Wisconsin

Phase 2 Recruiting
44 enrolled
Other solid neoplasmSarcoma

Chondrosarcoma, Retinoblastoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡